Merit Medical Systems (Nasdaq:MMSI) announced today that it received FDA 510(k) clearance for the Scout MD surgical guidance system.
Scout MD broadens the South Jordan, Utah–based company’s oncology portfolio. Merit designed the system to enhance the diagnosis and treatment of breast cancer, as well as other soft tissue cancers. The system includes the Scout radar localization system with Scout mini reflector and Scout Bx delivery system. It also features the Savi brachy system.
According to a news release, Scout MD supports the implantation of up to four different reflector configurations. When implanted within abnormal breast or other soft tissue, reflectors pinpoint tumor location in multiple dimensions. This enables more precise excision.
With a targeted approach, the system can help minimize damage to surrounding healthy tissue and decrease the likelihood of re-excision. Merit says it also helps to avoid the emotional and physical trauma assoc…